-
c-Myc Tag Peptide: Assay Control by Design
2026-08-26
Explore how the c-Myc tag peptide functions as a precise competitive control for antibody-based assays rather than as a cellular c-Myc inhibitor. This article connects epitope displacement, assay interpretation, and selective transcription-factor stability using evidence from IRF3 autophagy research.
-
PBS (Phosphate-Buffered Saline) Workflow Guide
2026-08-26
PBS (Phosphate-Buffered Saline), SKU K2818, provides a sterile, isotonic buffer at a defined physiological pH for cell washing, reagent dilution, and other routine in vitro workflows. It is supplied ready to use for research applications only and should not be used for diagnostic, medical, or in vivo procedures.
-
Saquinavir Workflows for HIV and Lung Permeability
2026-08-25
Build a two-axis workflow that measures Saquinavir activity against HIV protease while separately profiling phospholipid-membrane interactions. Biomimetic IAM-LC and OT-CEC-MS add practical permeability insight without treating chromatographic retention as a substitute for biological validation.
-
Insulin–AMPK Control of Pink1 mRNA in Neurons
2026-08-25
Hees and Harbauer identify an insulin–AMPK metabolic switch that controls whether Pink1 mRNA remains tethered to mitochondria in neurons. Their findings connect SYNJ2BP phosphorylation, PINK1 ubiquitin-kinase activation, and ApoE4-associated insulin resistance, providing a mechanistic framework for understanding how metabolic dysfunction may impair neuronal mitochondrial quality control.
-
N1-Methylpseudo-UTP for mRNA Assays
2026-08-24
N1-Methyl-Pseudouridine-5'-Triphosphate can reshape how researchers design, compare, and validate modified mRNA. This article connects nucleotide chemistry with assay-level decisions for RNA stability enhancement, translation studies, and mRNA vaccine development.
-
Puerarin, Gut Microbiota, and Adipose Thermogenesis
2026-08-24
This 2026 reference study presents an integrated mechanism by which puerarin improves glucose and lipid metabolism in Type 2 diabetes mice through coordinated regulation of gut microbiota, fecal metabolites, adipose thermogenesis, and insulin-related signaling. Its multi-omics and molecular validation strategy offers a useful framework for connecting microbial ecology with tissue-specific metabolic remodeling while highlighting important limits for translation beyond mouse models.
-
NS1–DNMT1 Control of HBoV1 RNA Processing
2026-08-23
A 2024 PLOS Pathogens study identifies a regulatory link between HBoV1 NS1, host DNMT1 degradation, viral DNA methylation, genome replication, and RNA maturation. The findings support a model in which DNMT1 promotes viral DNA synthesis, whereas NS1-driven DNMT1 removal favors RNA processing and viral protein expression.
-
DiscoveryProbe Protease Inhibitor Library Workflow
2026-08-22
Build phenotype-first and enzyme-based screens with 825 pre-dissolved protease inhibitors spanning diverse inhibitor classes. A plant stomatal-opening study illustrates how inhibitor panels can move beyond hit finding to pathway localization, while practical controls help separate protease inhibition from cytotoxicity, fluorescence artifacts, and general signaling disruption.
-
2-Hydroxypropyl-β-cyclodextrin Workflow Guide
2026-08-22
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide used to improve the apparent aqueous solubility of poorly soluble hydrophobic compounds, particularly molecules with aromatic or phenyl groups. This guide supports pharmaceutical and biochemical formulation workflows, but solubility improvement alone does not establish bioavailability, efficacy, safety, or suitability outside those settings.
-
Rucaparib (AG-014699) DNA Repair Workflows
2026-08-21
Rucaparib (AG-014699) enables controlled studies of PARP1 inhibition, persistent DNA breaks, and radiation response across repair-deficient cancer models. This practical guide connects radiosensitization of prostate cancer cells with emerging SmD2–BRCA1/FANC splicing biology in hepatocellular carcinoma.
-
PXDN–LDHA: Smarter Gene Delivery in GBM
2026-08-20
The PXDN–LDHA axis offers a compelling framework for studying glycolytic progression in glioblastoma. This thought-leadership article shows how careful nucleic acid delivery, low-toxicity workflows, and rescue experiments can convert a mechanistic observation into a more reproducible translational research program.
-
TNFα, Vasorin, and Glioma Stem Cell Self-Renewal
2026-08-20
This study identifies a dose-dependent paradox in glioma biology: low tumor necrosis factor α supports glioma stem cell self-renewal rather than suppressing it. The authors connect this effect to Vasorin-driven glycolysis and a lactate-mediated feedback loop involving tumor-associated macrophages, providing a mechanistic framework for interpreting TNFα resistance in glioblastoma.
-
Biotin-tyramide for TSA and Senescence Imaging
2026-08-19
Biotin-tyramide enables localized signal amplification for low-abundance RNA and protein targets in fixed cells and tissue. This practical guide connects TSA workflow design with the PURPL–H3K9me3 senescence model, while emphasizing controls, multiplexing, and troubleshooting.
-
Lysobacter Rewires DSF Signaling for Antifungal Defense
2026-08-19
This study shows that Lysobacter enzymogenes uses the DSF quorum-sensing component RpfG to regulate heat-stable antifungal factor production through a mechanism that is independent of RpfG phosphodiesterase activity. Its central innovation is the identification of three hybrid two-component proteins that connect RpfG interaction, phosphorylation-dependent regulation, and promoter control of antifungal biosynthesis.
-
X-ray Cherenkov Activation of Caged Doxorubicin
2026-08-18
Yao and colleagues developed folate-decorated nano-micelles that use X-ray-induced Cherenkov light to uncage doxorubicin and promote its redistribution into tumor-cell nuclei. The study combines receptor-directed uptake, localized radiation activation, and nuclear drug delivery to improve chemoradiation efficacy while reducing systemic exposure.